Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 2/2018

01-02-2018 | Correction

Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells

Authors: Tamson Moore, Courtney Regan Wagner, Gina M. Scurti, Kelli A. Hutchens, Constantine Godellas, Ann Lau Clark, Elizabeth Motunrayo Kolawole, Lance M. Hellman, Nishant K. Singh, Fernando A. Huyke, Siao-Yi Wang, Kelly M. Calabrese, Heather D. Embree, Rimas Orentas, Keisuke Shirai, Emilia Dellacecca, Elizabeth Garrett-Mayer, Mingli Li, Jonathan M. Eby, Patrick J. Stiff, Brian D. Evavold, Brian M. Baker, I. Caroline Le Poole, Boro Dropulic, Joseph I. Clark, Michael I. Nishimura

Published in: Cancer Immunology, Immunotherapy | Issue 2/2018

Login to get access

Excerpt

The authors would like to make the following corrections to the published article: …
Metadata
Title
Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells
Authors
Tamson Moore
Courtney Regan Wagner
Gina M. Scurti
Kelli A. Hutchens
Constantine Godellas
Ann Lau Clark
Elizabeth Motunrayo Kolawole
Lance M. Hellman
Nishant K. Singh
Fernando A. Huyke
Siao-Yi Wang
Kelly M. Calabrese
Heather D. Embree
Rimas Orentas
Keisuke Shirai
Emilia Dellacecca
Elizabeth Garrett-Mayer
Mingli Li
Jonathan M. Eby
Patrick J. Stiff
Brian D. Evavold
Brian M. Baker
I. Caroline Le Poole
Boro Dropulic
Joseph I. Clark
Michael I. Nishimura
Publication date
01-02-2018
Publisher
Springer Berlin Heidelberg
Published in
Cancer Immunology, Immunotherapy / Issue 2/2018
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-017-2102-z

Other articles of this Issue 2/2018

Cancer Immunology, Immunotherapy 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine